Latest Breaking News On - Trigger trial - Page 2 : vimarsana.com

CAMBRIDGE, Mass., April 24, 2024 Black Diamond Therapeutics, Inc. , a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with.

United kingdomUnited statesYoshie umemuraPatrick wenMario corsoBarrow neurological instituteDana farber cancer instituteHarvard medical schoolIvy brain tumor centerCompany masterkeyDiamond therapeutics incExchange commissionDiamond therapeuticsInvestigator sponsored trialGeneration covalentRecurrent glioblastoma